Spruce Street Capital LP
CIK 2050194 · Lihat di SEC EDGAR ↗
- Nilai Portofolio
- $509.7M
- Posisi
- 30
- Per tanggal
- 30 Juni 2026
#3.726 dari 9.443 berdasarkan nilai 13F · top 39.5%
Nilai portofolio QoQ: +22.5% 13F tidak mengungkapkan kas
- Bobot 10 kepemilikan teratas
- 70,24%
- Bobot 25 kepemilikan teratas
- 96,58%
- Posisi di atas 1%
- 24
- Jumlah posisi efektif
- 16,0
Berdasarkan kepemilikan ekuitas jangka panjang 13F saja (kas, obligasi, posisi jual tidak diungkapkan)
Perputaran Q2 2026: 9,79% Perkiraan pembelian $62.623.670 · penjualan $45.296.407
- Posisi baru
- 5
- Meningkat
- 8
- Menurun
- 1
- Tertutup
- 3
Di halaman ini
- Rincian sektor Bagaimana portofolio terbagi di berbagai sektor pasar.
- Portofolio Setiap saham yang dilaporkan dimiliki oleh institusi ini, dari 13F terbarunya.
- Taruhan baru terbesar Posisi baru yang dibuka pada kuartal terakhir.
- Pergerakan Teratas Peningkatan dan penurunan posisi terbesar pada kuartal ini.
- Posisi yang keluar Posisi yang sepenuhnya dijual oleh manajer pada kuartal lalu.
Rincian sektor
Healthcare
94,4%
Lainnya/Tidak terpetakan
5,6%
Portofolio lengkap 30 posisi
| Tipe | Rentetan | Tren 8 kuartal | |||||
|---|---|---|---|---|---|---|---|
| KNSA Kiniksa Pharmaceuticals International, plc - Class A Ordinary Shares | $58.710.577 | 11,52% | 918.070 | $22.065.394 | Naik ×2 | ||
| RLAY Relay Therapeutics, Inc. - Common Stock | $55.832.979 | 10,95% | 2.984.125 | $26.140.935 | |||
| LBRX LB Pharmaceuticals Inc - Common Stock | $44.663.240 | 8,76% | 1.376.159 | $11.018.374 | |||
| RLMD Relmada Therapeutics, Inc. - Common Stock | $44.227.990 | 8,68% | 6.391.328 | $1.229.782 | Naik ×2 | ||
| ANRO Alto Neuroscience, Inc. Common Stock | $35.706.910 | 7,01% | 1.353.047 | $6.590.589 | Naik ×2 | ||
| DNTH Dianthus Therapeutics, Inc. - Common Stock | $34.587.464 | 6,79% | 354.816 | $3.262.310 | Turun ×1 | ||
| ALKS Alkermes plc - Ordinary Shares | $28.496.383 | 5,59% | 543.876 | $17.252.186 | Naik ×1 | ||
| SVRA Savara, Inc. - Common Stock | $21.267.868 | 4,17% | 3.452.576 | $2.795.732 | Naik ×2 | ||
| PCVX Vaxcyte, Inc. - Common Stock | $17.790.512 | 3,49% | 306.047 | $3.512.362 | Naik ×1 | ||
| ELVN Enliven Therapeutics, Inc. - Common Stock | $16.697.055 | 3,28% | 329.006 | $3.800.020 | |||
| ENTA Enanta Pharmaceuticals, Inc. - Common Stock | $15.873.698 | 3,11% | 1.088.731 | $4.094.985 | Naik ×2 | ||
| CATX | $12.596.305 | 2,47% | 3.693.931 | $1.641.269 | Naik ×1 | ||
| IFRX InflaRx N.V. - Common Stock | $11.988.924 | 2,35% | 5.352.198 | Naik ×1 | |||
| SRZN Surrozen, Inc. - Common Stock | $11.211.438 | 2,20% | 432.040 | $-1.373.887 | |||
| ALMS Alumis Inc. - Common Stock | $11.047.032 | 2,17% | 392.574 | $2.398.627 | |||
| IPSC Century Therapeutics, Inc. - Common Stock | $9.944.682 | 1,95% | 4.059.054 | $771.220 | |||
| NERV Minerva Neurosciences, Inc - Common Stock | $9.188.025 | 1,80% | 1.655.500 | $-786.363 | |||
| SABS SAB Biotherapeutics, Inc. - Common Stock | $8.574.158 | 1,68% | 2.198.502 | $153.895 | |||
| ANTX AN2 Therapeutics, Inc. - Common Stock | $8.039.593 | 1,58% | 1.661.073 | $2.463.723 | |||
| ERAS Erasca, Inc. - Common Stock | $7.740.988 | 1,52% | 422.543 | $904.242 | |||
| IKT Inhibikase Therapeutics, Inc. - Common Stock | $7.270.654 | 1,43% | 3.581.603 | $1.253.561 | |||
| Penerbit tidak dikenal (CUSIP: G75226103) | $5.350.000 | 1,05% | 500.000 | Naik ×1 | |||
| HLXC Helix Acquisition Corp. III - Class A Ordinary Shares | $5.320.000 | 1,04% | 500.000 | $240.000 | |||
| ZLAB Zai Lab Limited - American Depositary Shares | $5.303.090 | 1,04% | 279.110 | Naik ×1 | |||
| ACHV Achieve Life Sciences, Inc. - Common Shares | $4.810.240 | 0,94% | 736.637 | Naik ×1 | |||
| LXEO Lexeo Therapeutics, Inc. - Common Stock | $4.322.600 | 0,85% | 928.593 | $-1.007.524 | |||
| ALEC Alector, Inc. - Common Stock | $4.223.147 | 0,83% | 2.101.068 | $-294.149 | |||
| LONA LeonaBio, Inc. - Common Stock | $3.618.112 | 0,71% | 393.701 | $-226.772 | |||
| CRVS Corvus Pharmaceuticals, Inc. - Common Stock | $3.459.880 | 0,68% | 231.585 | $71.791 | |||
| Penerbit tidak dikenal (CUSIP: G50765109) | $1.817.600 | 0,36% | 160.000 | Naik ×1 | |||
| Tidak ada hasil | |||||||
Taruhan baru terbesar
Posisi baru dibuka kuartal ini, terbesar diurutkan pertama.
Penggerak teratas (QoQ)
| Sekuritas | Aksi | Saham Δ | Nilai Δ |
|---|---|---|---|
| RLAY | Hanya pergerakan harga | +0 | +$26.1M |
| KNSA | Beli lebih banyak | +157K | +$22.1M |
| ALKS | Beli lebih banyak | +226K | +$17.3M |
| LBRX | Hanya pergerakan harga | +0 | +$11.0M |
| ANRO | Beli lebih banyak | +28K | +$6.6M |
| ENTA | Beli lebih banyak | +156K | +$4.1M |
| ELVN | Hanya pergerakan harga | +0 | +$3.8M |
| PCVX | Beli lebih banyak | +60K | +$3.5M |
| DNTH | Dipangkas | -18K | +$3.3M |
| SVRA | Beli lebih banyak | +69K | +$2.8M |
Posisi yang keluar
Termasuk peristiwa perusahaan (merger, delisting) — tidak semua keluar adalah penjualan
Posisi tertutup mencerminkan perubahan pelaporan 13F; bagi manajer indeks, ini sering kali mekanis (penghapusan pencatatan, M&A, penyeimbangan ulang indeks), bukan keputusan aktif.
| Sekuritas | Kuartal | Saham sebelumnya | Nilai sebelumnya | Harga sejak keluar |
|---|---|---|---|---|
| CDTX | 31 Maret 2026 | 232.269 | $51.305.899 | Tidak lagi dilacak |
| CNTA | 30 Juni 2026 | 489.849 | $19.456.802 | Tidak lagi dilacak |
| KALV | 30 Juni 2026 | 897.681 | $18.070.319 | Tidak lagi dilacak |
| EYPT | 31 Maret 2026 | 981.543 | $17.932.791 | -57,8% |
| OCUL | 31 Maret 2026 | 783.999 | $9.517.748 | 33,1% |
| ABVX | 31 Maret 2026 | 49.119 | $6.623.943 | 7,3% |
| HELP | 31 Maret 2026 | 770.000 | $6.298.600 | 162,1% |
| MAZE | 30 Juni 2026 | 200.000 | $5.970.000 | -2,6% |
| STRO | 31 Maret 2026 | 75.594 | $874.623 | -12,6% |